|
Brock
et al. measured the level of several phthalate metabolites
in the urine of 19 children living in the Imperial Valley, California.
They found phthalates in all children examined, with levels
higher on average than had been reported by Blount
et al. (2000) using the same analytical tools to measure
phthalate metabolites in a larger sample of American adults.
What
did they do? Brock et al. recruited 20 children (ages
12-18 months) for participation in this survey by approaching the
parents as the children were brought to a clinic for their measles-mumps-rubella
vaccine. Nothing was assumed or known about their potential exposure
to phthalates upon recruitment. 18 of the 20 subjects were Latino;
2 were Caucasian. Urine was collected during this clinic visit and
a second time during a home visit, about 4 weeks later. The primary
caregiver was interviewed using a questionnaire to assess home pesticide
use, occupational exposure and proximity to agricultural pesticide
use. A second interview was conducted during the home visit, updating
the pesticide information and also asking about the use of perfumes,
cosmetics and soft plastic toys.
The
phthalate measurements were conducted using procedures developed
for Blount et al. (2000). Because
phthalate exposure is so widespread that laboratory contamination
is unavoidable, Brock's lab at the CDC has pioneered a technique
that measures the breakdown products of different phthalates in
urine, their metabolites, instead of the original (parent) phthalates
themselves. According to Blount et al: "This analytical
approach allows us to directly measure the individual phthalate
metabolites responsible for the reproductive and developmental toxicity
of phthalates in animals while avoiding contamination from the ubiquitous
parent compound." This approach thus allows Brock's team to
confirm that the exposures were real and not due to laboratory contamination,
as the laboratory contamination is by the phthalates, not by their
metabolites.
They
report on the concentrations of the following metabolites:
|
Parent
phthalate
|
Metabolite
|
|
DEP
diethyl phthalate
|
MEP
monoethyl phthalate
|
|
DBP
dibutyl phthalate
|
MBP
monobutyl phthalate
|
|
BzBP
benzyl butyl phthalate
|
MBzP
monobenzyl phthalate
|
|
DEHP
di-(2-ethylhexyl) phthalate
|
MEHP
mono-(2-ethylhexyl) phthalate
|
Several
other metabolites were measured but were not detected.
What
did they find? All children had phthalate metabolites in their
urine, indicating exposure to the parent phthalates. For three of
the four metabolites, concentrations averaged higher in children
than those measured by Blount
et al. in adults:
|
Metabolite
|
Average
in children ng/ml
|
Percentile
in Blount et al.
|
|
MEP
|
246.9
|
25th-50th
|
|
MBP
|
287.6
|
75th-100th
|
|
MBzP
|
44.8
|
50th-75th
|
|
MEHP
|
6.4
|
50th-75th
|
None
of the measurements of phthalate metabolites showed any correlation
with responses to the questionnaires.
What
does it mean?
According
to Brock et al.:
| |
"The
mean urinary MBP, MBzP and MEHP levels for the children in this
study were above the 50th percentile of the previously reported
adult levels. This crude comparison neglects to consider that
infants produce about one third of the urine volume of adults
with about one seventh the body weight. Combining this information
suggests that DBP, BzBP and DEHP exposure on a body weight basis
may be at least twice as high for these children compared to
the adults in NHANES III" [Blount et al.'s sample]. |
|
The
types of phthalates detected suggest that exposure is via consumer
products such as fragrance-containing soaps, shampoos and perfumes,
as well as nail polish and beauty products. The presence of MEHP
indicates that another route of exposure was via DEHP-containing
toys.
Whether
these levels create health risks remains to be established. The
higher levels indicate exposures within the range at which effects
begin to appear in laboratory experiments with animals. The concluding
comments from Blount et al. (2000) are equally germane to
these new data:
| |
From
a public health perspective, these data provide evidence that
phthalate exposure is both higher and more common than previously
suspected. Exposure data for phthalates is critically important
for human risk assessment, especially among potentially susceptible
populations. Although DEHP and DINP are produced in the largest
quantities, these reference range data indicate a substantial
internal human dose of DBP, DEP, and BzBP. MBP and MBzP are
of particular concern because of their developmental and reproductive
toxicity in animals. Therefore, assessments of health risk from
exposures to phthalates should include exposures to DBP, DEP,
and BzBP. |
|
|